MetadataShow full item record
Abstractµ-Crystallin is a NADPH-regulated thyroid hormone binding protein encoded by the CRYM gene in humans. It is primarily expressed in the brain, muscle, prostate, and kidney, where it binds thyroid hormones, which regulate metabolism and thermogenesis. It also acts as a ketimine reductase in the lysine degradation pathway when it is not bound to thyroid hormone. Mutations in CRYM can result in non-syndromic deafness, while its aberrant expression, predominantly in the brain but also in other tissues, has been associated with psychiatric, neuromuscular, and inflammatory diseases. CRYM expression is highly variable in human skeletal muscle, with 15% of individuals expressing ≥13 fold more CRYM mRNA than the median level. Ablation of the Crym gene in murine models results in the hypertrophy of fast twitch muscle fibers and an increase in fat mass of mice fed a high fat diet. Overexpression of Crym in mice causes a shift in energy utilization away from glycolysis towards an increase in the catabolism of fat via β-oxidation, with commensurate changes of metabolically involved transcripts and proteins. The history, attributes, functions, and diseases associated with CRYM, an important modulator of metabolism, are reviewed.
Rights/Terms© 2021 Christian J. Kinney et al., published by Sciendo.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15852
- Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone.
- Authors: Borel F, Hachi I, Palencia A, Gaillard MC, Ferrer JL
- Issue date: 2014 Mar
- CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
- Authors: Oshima A, Suzuki S, Takumi Y, Hashizume K, Abe S, Usami S
- Issue date: 2006 Jun
- μ-Crystallin controls muscle function through thyroid hormone action.
- Authors: Seko D, Ogawa S, Li TS, Taimura A, Ono Y
- Issue date: 2016 May
- Loss of μ-crystallin causes PPARγ activation and obesity in high-fat diet-fed mice.
- Authors: Ohkubo Y, Sekido T, Nishio SI, Sekido K, Kitahara J, Suzuki S, Komatsu M
- Issue date: 2019 Jan 15
- Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
- Authors: Aksoy O, Pencik J, Hartenbach M, Moazzami AA, Schlederer M, Balber T, Varady A, Philippe C, Baltzer PA, Mazumder B, Whitchurch JB, Roberts CJ, Haitel A, Herac M, Susani M, Mitterhauser M, Marculescu R, Stangl-Kremser J, Hassler MR, Kramer G, Shariat SF, Turner SD, Tichy B, Oppelt J, Pospisilova S, Hartenbach S, Tangermann S, Egger G, Neubauer HA, Moriggl R, Culig Z, Greiner G, Hoermann G, Hacker M, Heery DM, Merkel O, Kenner L
- Issue date: 2021 Feb 1